Celecoxib upregulates ULBP‑1 expression in lung cancer cells via the JNK/PI3K signaling pathway and increases susceptibility to natural killer cell cytotoxicityJayoung Kim, Hyun-Kyung Lee|Oncology Letters|2020Cited by 11